Drug Approval Package

Veramyst (fluticasone furoate)
Company: GlaxoSmithKline
NDA: 022051
Approval Date: 4/27/2007

• Approval Letter(s) (PDF)
• Printed Labeling (PDF)
• Medical Review(s)
  • Part 1 (PDF)  
  • Part 2 (PDF)  
  • Part 3 (PDF)  
• Chemistry Review(s) (PDF)
• Environmental Assessment (PDF)
• Pharmacology Review(s) (PDF)
• Statistical Review(s) (PDF)
• Microbiology Review(s) (PDF)
• Clinical Pharmacology Biopharmaceutics Review(s) (PDF)  
• Proprietary Name Review(s) (PDF)
• Administrative Document(s) and Correspondence (PDF)
  
  • Part 1 (PDF)
  • Part 2 (PDF)
  • Part 3 (PDF)

Date created: November 3, 2008
Updated: July 16, 2012

Back to Top    Drugs@FDA

Note: Documents in PDF format require the Adobe Acrobat Reader®.